SurModics, Inc.
SRDX
$30.11
-$0.65-2.11%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.95% | 9.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.95% | 9.51% | |||
| Cost of Revenue | 181.90% | -209.72% | |||
| Gross Profit | -74.52% | 338.75% | |||
| SG&A Expenses | 18.34% | -34.57% | |||
| Depreciation & Amortization | -2.49% | 1.72% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.12% | -15.60% | |||
| Operating Income | -105.86% | 157.50% | |||
| Income Before Tax | -158.93% | 80.43% | |||
| Income Tax Expenses | -69.42% | 32.64% | |||
| Earnings from Continuing Operations | -5.86% | 54.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.86% | 54.34% | |||
| EBIT | -105.86% | 157.50% | |||
| EBITDA | -63.61% | 261.15% | |||
| EPS Basic | -5.55% | 54.40% | |||
| Normalized Basic EPS | -125.07% | 144.05% | |||
| EPS Diluted | -4.08% | 53.14% | |||
| Normalized Diluted EPS | -125.07% | 144.05% | |||
| Average Basic Shares Outstanding | 0.30% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.30% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
